Form 4 for PRTA PROTHENA CORP PUBLIC LTD CO
Accepted 2021-07-30 00:00:00 ET · period of report 2021-07-30 · accession 0001140361-21-026291 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-30 | 2021-07-30 | PRTA | Selkoe Dennis J. | Dir | S - Sale+OE | $49.47 | -5,000 | 5,563 | -47% | -$247.4K |
| DM | 2021-07-30 | 2021-07-30 | PRTA | Selkoe Dennis J. | Dir | M - OptEx | $14.26 | +5,000 | 6,345 | +372% | +$71.3K |
| DM | 2021-07-30 | 2021-07-30 | PRTA | Selkoe Dennis J. | Dir | M - OptEx | $0.00 | -5,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, par value $0.01 per share | 2021-07-30 | S | D | 2,718 | $49.88 | 2,845 | D | — | — | (F3) The transaction was executed in multiple trades in prices ranging from $49.67 to $50.265, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Ordinary Shares, par value $0.01 per share | 2021-07-30 | S | D | 2,282 | $48.99 | 5,563 | D | — | — | (F2) The transaction was executed in multiple trades in prices ranging from $48.34 to $49.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Ordinary Shares, par value $0.01 per share | 2021-07-30 | M | A | 1,500 | $9.23 | 7,845 | D | — | — | |
| 4 | Common | Ordinary Shares, par value $0.01 per share | 2021-07-30 | M | A | 3,500 | $16.42 | 6,345 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-07-30 | M | D | 1,500 | $0.00 | 16,000 | D | $9.23 · 2020-05-18 to 2029-05-22 | 1,500 Ordinary Shares | |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-07-30 | M | D | 3,500 | $0.00 | 0 | D | $16.42 · 2014-07-22 to 2023-07-21 | 3,500 Ordinary Shares |